122 related articles for article (PubMed ID: 29073105)
1. PAF promotes stemness and radioresistance of glioma stem cells.
Ong DST; Hu B; Ho YW; Sauvé CG; Bristow CA; Wang Q; Multani AS; Chen P; Nezi L; Jiang S; Gorman CE; Monasterio MM; Koul D; Marchesini M; Colla S; Jin EJ; Sulman EP; Spring DJ; Yung WA; Verhaak RGW; Chin L; Wang YA; DePinho RA
Proc Natl Acad Sci U S A; 2017 Oct; 114(43):E9086-E9095. PubMed ID: 29073105
[TBL] [Abstract][Full Text] [Related]
2. G-quadruplex ligand RHPS4 radiosensitizes glioblastoma xenograft in vivo through a differential targeting of bulky differentiated- and stem-cancer cells.
Berardinelli F; Tanori M; Muoio D; Buccarelli M; di Masi A; Leone S; Ricci-Vitiani L; Pallini R; Mancuso M; Antoccia A
J Exp Clin Cancer Res; 2019 Jul; 38(1):311. PubMed ID: 31311580
[TBL] [Abstract][Full Text] [Related]
3. Replication Stress Drives Constitutive Activation of the DNA Damage Response and Radioresistance in Glioblastoma Stem-like Cells.
Carruthers RD; Ahmed SU; Ramachandran S; Strathdee K; Kurian KM; Hedley A; Gomez-Roman N; Kalna G; Neilson M; Gilmour L; Stevenson KH; Hammond EM; Chalmers AJ
Cancer Res; 2018 Sep; 78(17):5060-5071. PubMed ID: 29976574
[TBL] [Abstract][Full Text] [Related]
4. N-cadherin upregulation mediates adaptive radioresistance in glioblastoma.
Osuka S; Zhu D; Zhang Z; Li C; Stackhouse CT; Sampetrean O; Olson JJ; Gillespie GY; Saya H; Willey CD; Van Meir EG
J Clin Invest; 2021 Mar; 131(6):. PubMed ID: 33720050
[TBL] [Abstract][Full Text] [Related]
5. Radiation Drives the Evolution of Orthotopic Xenografts Initiated from Glioblastoma Stem-like Cells.
McAbee JH; Rath BH; Valdez K; Young DL; Wu X; Shankavaram UT; Camphausen K; Tofilon PJ
Cancer Res; 2019 Dec; 79(23):6032-6043. PubMed ID: 31615806
[TBL] [Abstract][Full Text] [Related]
6. MET inhibition overcomes radiation resistance of glioblastoma stem-like cells.
De Bacco F; D'Ambrosio A; Casanova E; Orzan F; Neggia R; Albano R; Verginelli F; Cominelli M; Poliani PL; Luraghi P; Reato G; Pellegatta S; Finocchiaro G; Perera T; Garibaldi E; Gabriele P; Comoglio PM; Boccaccio C
EMBO Mol Med; 2016 May; 8(5):550-68. PubMed ID: 27138567
[TBL] [Abstract][Full Text] [Related]
7. Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment.
Wang Q; Hu B; Hu X; Kim H; Squatrito M; Scarpace L; deCarvalho AC; Lyu S; Li P; Li Y; Barthel F; Cho HJ; Lin YH; Satani N; Martinez-Ledesma E; Zheng S; Chang E; Gabriel Sauvé CE; Olar A; Lan ZD; Finocchiaro G; Phillips JJ; Berger MS; Gabrusiewicz KR; Wang G; Eskilsson E; Hu J; Mikkelsen T; DePinho RA; Muller F; Heimberger AB; Sulman EP; Nam DH; Verhaak RGW
Cancer Cell; 2018 Jan; 33(1):152. PubMed ID: 29316430
[No Abstract] [Full Text] [Related]
8. Inhibition of TRF1 Telomere Protein Impairs Tumor Initiation and Progression in Glioblastoma Mouse Models and Patient-Derived Xenografts.
Bejarano L; Schuhmacher AJ; Méndez M; Megías D; Blanco-Aparicio C; Martínez S; Pastor J; Squatrito M; Blasco MA
Cancer Cell; 2017 Nov; 32(5):590-607.e4. PubMed ID: 29136505
[TBL] [Abstract][Full Text] [Related]
9. GPR56/ADGRG1 Inhibits Mesenchymal Differentiation and Radioresistance in Glioblastoma.
Moreno M; Pedrosa L; Paré L; Pineda E; Bejarano L; Martínez J; Balasubramaniyan V; Ezhilarasan R; Kallarackal N; Kim SH; Wang J; Audia A; Conroy S; Marin M; Ribalta T; Pujol T; Herreros A; Tortosa A; Mira H; Alonso MM; Gómez-Manzano C; Graus F; Sulman EP; Piao X; Nakano I; Prat A; Bhat KP; de la Iglesia N
Cell Rep; 2017 Nov; 21(8):2183-2197. PubMed ID: 29166609
[TBL] [Abstract][Full Text] [Related]
10. Targeting Glioma Stem Cell-Derived Pericytes Disrupts the Blood-Tumor Barrier and Improves Chemotherapeutic Efficacy.
Zhou W; Chen C; Shi Y; Wu Q; Gimple RC; Fang X; Huang Z; Zhai K; Ke SQ; Ping YF; Feng H; Rich JN; Yu JS; Bao S; Bian XW
Cell Stem Cell; 2017 Nov; 21(5):591-603.e4. PubMed ID: 29100012
[TBL] [Abstract][Full Text] [Related]
11. Single-Cell RNA-Seq Analysis of Infiltrating Neoplastic Cells at the Migrating Front of Human Glioblastoma.
Darmanis S; Sloan SA; Croote D; Mignardi M; Chernikova S; Samghababi P; Zhang Y; Neff N; Kowarsky M; Caneda C; Li G; Chang SD; Connolly ID; Li Y; Barres BA; Gephart MH; Quake SR
Cell Rep; 2017 Oct; 21(5):1399-1410. PubMed ID: 29091775
[TBL] [Abstract][Full Text] [Related]
12. TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma.
Lv D; Li Y; Zhang W; Alvarez AA; Song L; Tang J; Gao WQ; Hu B; Cheng SY; Feng H
Nat Commun; 2017 Nov; 8(1):1454. PubMed ID: 29129908
[TBL] [Abstract][Full Text] [Related]
13. Coding and noncoding landscape of extracellular RNA released by human glioma stem cells.
Wei Z; Batagov AO; Schinelli S; Wang J; Wang Y; El Fatimy R; Rabinovsky R; Balaj L; Chen CC; Hochberg F; Carter B; Breakefield XO; Krichevsky AM
Nat Commun; 2017 Oct; 8(1):1145. PubMed ID: 29074968
[TBL] [Abstract][Full Text] [Related]
14. Opposing roles of TGFβ and BMP signaling in prostate cancer development.
Lu X; Jin EJ; Cheng X; Feng S; Shang X; Deng P; Jiang S; Chang Q; Rahmy S; Chaudhary S; Lu X; Zhao R; Wang YA; DePinho RA
Genes Dev; 2017 Dec; 31(23-24):2337-2342. PubMed ID: 29352019
[TBL] [Abstract][Full Text] [Related]
15. H3.3
Pathania M; De Jay N; Maestro N; Harutyunyan AS; Nitarska J; Pahlavan P; Henderson S; Mikael LG; Richard-Londt A; Zhang Y; Costa JR; Hébert S; Khazaei S; Ibrahim NS; Herrero J; Riccio A; Albrecht S; Ketteler R; Brandner S; Kleinman CL; Jabado N; Salomoni P
Cancer Cell; 2017 Nov; 32(5):684-700.e9. PubMed ID: 29107533
[TBL] [Abstract][Full Text] [Related]
16. Low-Grade Astrocytoma Mutations in IDH1, P53, and ATRX Cooperate to Block Differentiation of Human Neural Stem Cells via Repression of SOX2.
Modrek AS; Golub D; Khan T; Bready D; Prado J; Bowman C; Deng J; Zhang G; Rocha PP; Raviram R; Lazaris C; Stafford JM; LeRoy G; Kader M; Dhaliwal J; Bayin NS; Frenster JD; Serrano J; Chiriboga L; Baitalmal R; Nanjangud G; Chi AS; Golfinos JG; Wang J; Karajannis MA; Bonneau RA; Reinberg D; Tsirigos A; Zagzag D; Snuderl M; Skok JA; Neubert TA; Placantonakis DG
Cell Rep; 2017 Oct; 21(5):1267-1280. PubMed ID: 29091765
[TBL] [Abstract][Full Text] [Related]
17. PRMT5 as a druggable target for glioblastoma therapy.
Banasavadi-Siddegowda YK; Welker AM; An M; Yang X; Zhou W; Shi G; Imitola J; Li C; Hsu S; Wang J; Phelps M; Zhang J; Beattie CE; Baiocchi R; Kaur B
Neuro Oncol; 2018 May; 20(6):753-763. PubMed ID: 29106602
[TBL] [Abstract][Full Text] [Related]
18. Lomustine and Bevacizumab in Progressive Glioblastoma.
Wick W; Gorlia T; Bendszus M; Taphoorn M; Sahm F; Harting I; Brandes AA; Taal W; Domont J; Idbaih A; Campone M; Clement PM; Stupp R; Fabbro M; Le Rhun E; Dubois F; Weller M; von Deimling A; Golfinopoulos V; Bromberg JC; Platten M; Klein M; van den Bent MJ
N Engl J Med; 2017 Nov; 377(20):1954-1963. PubMed ID: 29141164
[TBL] [Abstract][Full Text] [Related]
19. Radioresistance of mesenchymal glioblastoma initiating cells correlates with patient outcome and is associated with activation of inflammatory program.
Stanzani E; Martínez-Soler F; Mateos TM; Vidal N; Villanueva A; Pujana MA; Serra-Musach J; de la Iglesia N; Giménez-Bonafé P; Tortosa A
Oncotarget; 2017 Sep; 8(43):73640-73653. PubMed ID: 29088733
[TBL] [Abstract][Full Text] [Related]
20. MST4 Phosphorylation of ATG4B Regulates Autophagic Activity, Tumorigenicity, and Radioresistance in Glioblastoma.
Huang T; Kim CK; Alvarez AA; Pangeni RP; Wan X; Song X; Shi T; Yang Y; Sastry N; Horbinski CM; Lu S; Stupp R; Kessler JA; Nishikawa R; Nakano I; Sulman EP; Lu X; James CD; Yin XM; Hu B; Cheng SY
Cancer Cell; 2017 Dec; 32(6):840-855.e8. PubMed ID: 29232556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
